Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,919.00p

Change Today:

20.00p
52 Week High: 2,340.00
52 Week Low: 1,772.00

Currency: UK Pounds
Shares Issued: 234.72m
Volume: 10,543

Market Cap: £4,504.27m
RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart

6 Month Chart

More Hikma Pharmaceuticals charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	3.2%	0.0%
Div Cover	2.8	n/a
Op Mrgn	19.6%	n/a
ROCE	24.3%

	Latest	F'cast
P/E	11.3	n/a
PEG	25.2	n/a
Pr/Revenue	1.9	n/a
Pr/Book	2.6

	Latest	F'cast
Revenue	8.8%	n/a
PBT	61.9%	n/a
EPS	0.4%	n/a
DPS	11.1%	n/a

HIK Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	2,341.00	558.00	172.90¢	19.4	1.3	+15%	50.00¢	1.5%
31-Dec-21	2,553.00	544.00	194.80¢	15.2	1.2	+13%	54.00¢	1.8%
31-Dec-22	2,517.00	233.00	181.00¢	11.4	n/a	-7%	56.00¢	2.7%
31-Dec-23	2,875.00	281.00	223.00¢	10.7	0.5	+23%	72.00¢	3.0%
31-Dec-24	3,127.00	455.00	224.00¢	11.9	n/a	0%	80.00¢	3.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Company Announcements

Result of AGM	24-Apr-2025	15:55	RNS
Trading Statement	24-Apr-2025	07:00	RNS
Director/PDMR Shareholding	10-Apr-2025	14:36	RNS

More Hikma Pharmaceuticals hik company announcements

HIK ShareCast News

London close: Stocks manage small gains after US...	24-Apr-2025	ShareCast
Hikma Pharmaceuticals reaffirms guidance after s...	24-Apr-2025	ShareCast
London close: Stocks rise as investors look to N...	26-Feb-2025	ShareCast

More Hikma Pharmaceuticals ShareCast news

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal	29-May-2014	Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic...	08-May-2014	Daily Mail
Hikma prepares return to Libya	26-Aug-2011	The Independent

Latest HIK Director Deals

Traded	Action	Notifier	Price	Amount	Value
08-Apr-25	Sell	Victoria Hull	1,800.00p	2,777	£49,986.00
28-Feb-25	Transfer From	Mazen Darwazah	0.000p	14,844	£0.00
28-Feb-25	Transfer From	Riad Mishlawi	0.000p	38,581	£0.00

More Hikma Pharmaceuticals director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

HIK Market Data

Currency	UK Pounds
Share Price	1,919.00p
Change Today	20.00p
% Change	1.05 %
52 Week High	2,340.00
52 Week Low	1,772.00
Volume	10,543
Shares Issued	234.72m
Market Cap	£4,504.27m
RiskGrade	125